The 'disconnect' between initial judgments of lamotrigine vs. its real-world effectiveness in managing bipolar disorder. A tale with wider ramifications

Acta Psychiatrica Scandinavica

Volumn 132, Issue 5, 2015, Pages 345-354

  Parker, Gordon ^a,b   Mccraw, S ^a,b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b BLACK DOG INSTITUTE   (Australia)

Author keywords

Bipolar disorder; Depression; Lamotrigine; Randomized controlled trial; Review

Indexed keywords

CARBAMAZEPINE; LAMOTRIGINE; LITHIUM; ANTICONVULSIVE AGENT; TRIAZINE DERIVATIVE;

ARTICLE; BIPOLAR I DISORDER; BIPOLAR II DISORDER; CLINICAL EFFECTIVENESS; CONTROLLED CLINICAL TRIAL (TOPIC); DRUG EFFICACY; FOLLOW UP; HUMAN; MAINTENANCE THERAPY; MONOTHERAPY; OUTCOME ASSESSMENT; PHARMACEUTICAL CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); TREATMENT RESPONSE; BIPOLAR DISORDER;

ANTICONVULSANTS; BIPOLAR DISORDER; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); RANDOMIZED CONTROLLED TRIALS AS TOPIC; TRIAZINES;

EID: 84944173992     PISSN: 0001690X     EISSN: 16000447     Source Type: Journal    
DOI: 10.1111/acps.12427     Document Type: Article

References (32)

1. Wells KB. Treatment research at the crossroads: the scientific interface of clinical trials and effectiveness research. Am J Psychiatry 1999;156:5-10.
2. Calabrese JR, Fatemi SH, Woyshville MJ. Antidepressant effects of lamotrigine in rapid cycling bipolar disorder (letter). Am J Psychiatry 1996;153:1236.
3. Fatemi SH, Rapport DJ, Calabrese JR et al. Lamotrigine in rapid-cycling bipolar disorder. J Clin Psychiatry 1997;58:522-527.
4. Calabrese JR, Bowden CL, Sachs GS et al. A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group. J Clin Psychiatry 1999;60:79-88.
5. Calabrese JR, Bowden CL, Mcelroy SL et al. Efficacy of lamotrigine in bipolar disorder: preliminary data. In: Manji HK, Bowden C, Belmaker R, eds. Bipolar medications: mechanisms of action. Washington, DC: American Psychiatric Press, 1997:367-374.
6. Cookson J, Kundu S, Anderson J et al. Lamotrigine in treatment - refractory bipolar disorder. J Psychopharmacol 1996;10(suppl):A39.
7. Bowden CL, Calabrese JR, Mcelroy SL et al. The efficacy of lamotrigine in rapid cycling and non-rapid cycling patients with bipolar disorder. Biol Psychiatry 1999;45:953-958.
8. Frye MA, Ketter TA, Kimbrell TA et al. A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders. J Clin Psychopharmacol 2000;20:607-614.
9. Obrocea GV, Dunn RM, Frye MA et al. Clinical predictors of response to lamotrigine and gabapentin monotherapy in refractory affective disorders. Biol Psychiatry 2002;51:253-260.
10. Suppes T, Marangell LB, Bernstein IH et al. A single blind comparison of lithium and lamotrigine for the treatment of bipolar II depression. J Affect Disord 2008;111:334-343.
11. van der Loos ML, Mulder PG, Hartong EG et al. Efficacy and safety of lamotrigine as add-on treatment to lithium in bipolar depression: a multicenter, double-blind, placebo-controlled trial. J Clin Psychiatry 2009;70:223-231.
12. van der Loos ML, Mulder P, Hartong EG et al. Long-term outcome of bipolar depressed patients receiving lamotrigine as add-on to lithium with the possibility of the addition of paroxetine in nonresponders: a randomized, placebo-controlled trial with a novel design. Bipolar Disord 2011;13:111-117.
13. Calabrese JR, Huffman RF, White RL et al. Lamotrigine in the acute treatment of bipolar depression: results of five double-blind, placebo-controlled clinical trials. Bipolar Disord 2008;10:323-333.
14. Geddes JR, Calabrese JR, Goodwin GM. Lamotrigine for treatment of bipolar depression: independent meta-analysis and meta-regression of individual patient data from five randomised trials. Br J Psychiatry 2009;194:4-9.
15. Ketter TA, Brooks JO, Hoblyn JC et al. Effectiveness of lamotrigine in bipolar disorder in a clinical setting. J Psychiatr Res 2008;43:13-23.
16. Calabrese JR, Vieta E, Shelton MD. Latest maintenance data on lamotrigine in bipolar disorder. Eur Neuropsychopharmacol 2003;13(suppl 2):S 57-S 66.
17. Bowden CL, Calabrese JR, Sachs G et al. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder. Arch Gen Psychiatry 2003;60:392-400.
18. Goodwin GM, Bowden CL, Calabrese JR et al. A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder. J Clin Psychiatry 2004;65:432-441.
19. van der Loos MLM, Mulder P, Hartong EGTM et al. Efficacy and safety of two treatment algorithms in bipolar depression consisting of a combination of lithium, lamotrigine or placebo and paroxetine. Acta Psychiatr Scand 2010;122:246-254.
20. Licht RW, Nielson JN, Gram LF et al. Lamotrigine versus lithium as maintenance treatment in bipolar I disorder: an open, randomized effectiveness study mimicking clinical practice. The 6th trial of the Danish University Antidepressant Group (DUAG-6). Bipolar Disord 2010;12:483-493.
21. Calabrese JR, Rapport DJ, Youngstrom EA et al. New data on the use of lithium, divalproate, and lamotrigine in rapid cycling bipolar disorder. Eur Psychiatry 2005;20:92-95.
22. Calabrese JR, Suppes T, Bowden CL et al. A double-blind, placebo-controlled, prophylaxis study of lamotrigine in rapid-cycling bipolar disorder. Lamictal 614 Study Group. J Clin Psychiatry 2000;61:841-850.
23. Smith LA, Cornelius V, Warnock A et al. Effectiveness of mood stabilizers and antipsychotics in the maintenance phase of bipolar disorder: a systematic review of randomized controlled trials. Bipolar Disord 2007;9:394-412.
24. Soares-Weiser K, Bravo Vergel Y, Beynon S et al. A systematic review and economic model of the clinical effectiveness and cost effectiveness of interventions for preventing relapse in people with bipolar disorder. Health Technol Assess 2007;11:1-6.
25. Bowden CL, Singh V, Weisler R et al. Lamotrigine vs. lamotrigine plus divalproex in randomized, placebo-controlled maintenance treatment for bipolar depression. Acta Psychiatr Scand 2012;126:342-350.
26. Parker G, Graham RK, Fletcher K et al. The impact of being newly diagnosed with a bipolar disorder and the short-term outcome of disorder-specific management. Bipolar Disord 2014;16:172-179.
27. Parker G. Bipolar II disorder: modelling, measuring and managing. Cambridge: Cambridge University Press, 2008.
28. Parker G. Bipolar II disorder: modelling, measuring and managing (2nd edn). Cambridge: Cambridge University Press, 2012.
29. Born C, Bernhard B, Dittmann S et al. Lamotrigine in bipolar disorder: results of a mirror-image evaluation using the NIMH Lifechart-Methodology. J Affect Disord 2009;115:241-245.
30. Goldberg JF, Bowden CL, Calabrese JR et al. Six-month prospective life charting of mood symptoms with lamotrigine monotherapy versus placebo in rapid cycling bipolar disorder. Biol Psychiatry 2008;63:125-130.
31. Fournier JC, Derubeis RJ, Hollon SD et al. Antidepressant drug effects and depression severity: a patient-level meta-analysis. JAMA 2010;303:47-53.
32. Hotopf M, Lewis G, Normand C. Putting trials on trial - the costs and consequences of small trials in depression: a systematic review of methodology. J Epidemiol Community Health 1997;51:354-358.